ChenGuang Biotech Group Statistics
Total Valuation
SHE:300138 has a market cap or net worth of CNY 7.00 billion. The enterprise value is 8.76 billion.
| Market Cap | 7.00B |
| Enterprise Value | 8.76B |
Important Dates
The next confirmed earnings date is Tuesday, March 31, 2026.
| Earnings Date | Mar 31, 2026 |
| Ex-Dividend Date | May 16, 2025 |
Share Statistics
SHE:300138 has 483.10 million shares outstanding. The number of shares has decreased by -8.00% in one year.
| Current Share Class | 483.10M |
| Shares Outstanding | 483.10M |
| Shares Change (YoY) | -8.00% |
| Shares Change (QoQ) | -2.73% |
| Owned by Insiders (%) | 30.85% |
| Owned by Institutions (%) | 9.04% |
| Float | 334.04M |
Valuation Ratios
The trailing PE ratio is 18.98 and the forward PE ratio is 15.10.
| PE Ratio | 18.98 |
| Forward PE | 15.10 |
| PS Ratio | 1.07 |
| PB Ratio | 2.07 |
| P/TBV Ratio | 2.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 24.09 |
| EV / Sales | 1.33 |
| EV / EBITDA | 14.47 |
| EV / EBIT | 19.96 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.13 |
| Debt / EBITDA | 6.35 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 11.12% and return on invested capital (ROIC) is 7.12%.
| Return on Equity (ROE) | 11.12% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.12% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.12% |
| Revenue Per Employee | 3.51M |
| Profits Per Employee | 194,255 |
| Employee Count | 1,872 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SHE:300138 has paid 76.77 million in taxes.
| Income Tax | 76.77M |
| Effective Tax Rate | 17.43% |
Stock Price Statistics
The stock price has increased by +67.63% in the last 52 weeks. The beta is 0.67, so SHE:300138's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +67.63% |
| 50-Day Moving Average | 13.48 |
| 200-Day Moving Average | 13.02 |
| Relative Strength Index (RSI) | 62.50 |
| Average Volume (20 Days) | 10,382,743 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300138 had revenue of CNY 6.56 billion and earned 363.65 million in profits. Earnings per share was 0.76.
| Revenue | 6.56B |
| Gross Profit | 438.91M |
| Operating Income | 438.91M |
| Pretax Income | 440.42M |
| Net Income | 363.65M |
| EBITDA | 605.12M |
| EBIT | 438.91M |
| Earnings Per Share (EPS) | 0.76 |
Balance Sheet
The company has 2.14 billion in cash and 3.84 billion in debt, giving a net cash position of -1.70 billion or -3.52 per share.
| Cash & Cash Equivalents | 2.14B |
| Total Debt | 3.84B |
| Net Cash | -1.70B |
| Net Cash Per Share | -3.52 |
| Equity (Book Value) | 3.39B |
| Book Value Per Share | 6.90 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 6.69%, with operating and profit margins of 6.69% and 5.54%.
| Gross Margin | 6.69% |
| Operating Margin | 6.69% |
| Pretax Margin | 6.71% |
| Profit Margin | 5.54% |
| EBITDA Margin | 9.22% |
| EBIT Margin | 6.69% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.92%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 0.92% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.00% |
| Shareholder Yield | 8.93% |
| Earnings Yield | 5.19% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 27, 2018. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 27, 2018 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |